InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.23
(
0.77%
)
US TECH 100
19,408.75
(
1.26%
)
Dow Jones
38,778.10
(
0.49%
)
Brent Oil
83.77
(
-0.16%
)
Bitcoin
64,902.01
(
-2.38%
)
Post# of 3562
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: midastouch017 post# 1496

Monday, 02/19/2007 11:48:36 AM

Monday, February 19, 2007 11:48:36 AM

Post# of 3562
Tysabri had a nice start but it is not a threat to Copaxone in the near future here are a few points that Citi did not mentioned:
Tysabri is not a first line treatment, one has to fail the first line before switching to Tysabri.
The production ability of Tysabri is limited after Biogen sold the main facility that was suppose to produce it to Genentech.
Tysabri's cost is $28,400 per year, higher than the competitors.
Teva is testing high dose (44mg)of Copaxone in phase III and also
a new drug-Laquinimod (that might be the first oral drug for MS).
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent TEVA News
More TEVA News
InvestorsHub NewsWire

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM

HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM

Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM

Start posting your company's news
Only $200 per official company press release!